Full Breakdown
U.S. PEPFAR Data Reveal Sharp Decline in HIV Services Amid Trump Administration Cuts
4/25/2026, 10:04:26 PM
Background & Context
PEPFAR, launched by President George W. Bush in 2003 with $5 billion annually, has been credited with saving 26 million lives. In 2025 the Trump administration froze and cut foreign aid.
Core Findings & Statistics
State Department data for Q4 2025 show 20.6 million people on HIV treatment, a figure that includes roughly 3 million receiving care from their own governments. Independent analysis finds a 22 % decline in testing (4.7 million fewer tests), a 20 % fall in new diagnoses (78 000 fewer cases), and a 10 % reduction in preventive treatment (2 million fewer individuals). Frontline health-worker staffing dropped about 24 %, and in clinics with service interruptions new diagnoses fell nearly 30 %. Pregnant and breastfeeding women starting PrEP rose from 43 000 to 103 000.
Official Statements & Responses
Acting undersecretary Jeremy Lewin described the latest figures as very good and praised program resilience. A State Department spokesperson said President Donald Trump and Secretary of State Marco Rubio are “building to end the HIV/AIDS epidemic” under the America First Global Health Strategy and highlighted a “generous multi-year package of U.S. assistance” offered to Zambia. The spokesperson also cited continued funding for treatment in 50 countries.
Criticism & Opposition
Health GAP’s Asia Russell called the data “a five-alarm fire.” amfAR’s Brian Honermann said the figures “obscure the true damage of the interruptions.” Charles Kenny warned that missed testing “builds up problems for the future.” In South Africa, researcher Emily Bass warned that the loss of community-level prevention and NIH-funded trials “destroyed the platform” for new injectable drugs. Former chief science officer Mike Reid criticized aid being tied to critical-minerals deals.
On-the-Ground Reports
South African health workers report the abrupt loss of mobile testing vans, peer-support groups, and laboratory capacity, leaving “hundreds of thousands” of potential diagnoses unrecorded.
Conflicting Reports & Gaps
The State Department stresses a stable 20.6 million on treatment, yet analysts note a slight enrollment decline and that the count “includes about 3 million” from domestic programs. Data cover only Q4 2025, omitting earlier trends.
Verbatim Quotes
- “The numbers are very, very good,” — Jeremy Lewin, acting undersecretary of state for foreign assistance, humanitarian affairs and religious freedom
- “These data show nothing less than a five-alarm fire,” — Asia Russell, executive director, Health GAP
- “ Brian Honermann, deputy director of public policy at amfAR, says that the data presented by the State Department "obscures the true damage of the interruptions.” — Brian Honermann, deputy director of public policy, amfAR
- “When access to treatment or prevention becomes entangled with access to critical minerals or geopolitical positioning, the work is no longer what it claims to be,” — Mike Reid, chief science officer, PEPFAR
What’s Next
Advocates and the Partnership for HIV Research (PHR) call on the U.S. government to restore funding for community testing, research collaborations, and diplomatic engagement with South Africa and Zambia. Monitoring of PEPFAR metrics is slated for a mid-2026 congressional review.
